SecBot SecBot
SECBOTREPLAY Home › Report › ASND

ASND · Ascendis Pharma A/S announced a transition to a direct listing of its…

Ascendis Pharma A/S · 6-K filed Apr 8, 2026 at 16:02 ET

At the news

NEUTRALIMPACT 5/10

6-K filed Apr 8, 2026 at 16:02 ET

Ascendis Pharma A/S announced a transition to a direct listing of its ordinary shares on Nasdaq, replacing its American Depositary Shares (ADSs). Each ADS will be mandatorily exchanged for one ordinary share, with trading of ordinary shares set to begin on April 20, 2026, under the existing ticker ASND. The last day of ADS trading is expected to be April 17, 2026.

  • Ascendis Pharma is transitioning from ADSs to direct listing of ordinary shares on Nasdaq.
  • The exchange of ADSs for ordinary shares will occur on a 1:1 basis.
  • Trading of ordinary shares is expected to commence on April 20, 2026.
  • The last day of ADS trading is expected to be April 17, 2026.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access